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Wrangling environmental exposure data:
guidance for getting the best information
from your laboratory measurements
Julia O. Udesky1* , Robin E. Dodson1, Laura J. Perovich1,2 and Ruthann A. Rudel1*
Abstract
Background: Environmental health and exposure researchers can improve the quality and interpretation of their
chemical measurement data, avoid spurious results, and improve analytical protocols for new chemicals by closely
examining lab and field quality control (QC) data. Reporting QC data along with chemical measurements in
biological and environmental samples allows readers to evaluate data quality and appropriate uses of the data (e.g.,
for comparison to other exposure studies, association with health outcomes, use in regulatory decision-making).
However many studies do not adequately describe or interpret QC assessments in publications, leaving readers
uncertain about the level of confidence in the reported data. One potential barrier to both QC implementation and
reporting is that guidance on how to integrate and interpret QC assessments is often fragmented and difficult to
find, with no centralized repository or summary. In addition, existing documents are typically written for regulatory
scientists rather than environmental health researchers, who may have little or no experience in analytical
chemistry.
Objectives: We discuss approaches for implementing quality assurance/quality control (QA/QC) in environmental
exposure measurement projects and describe our process for interpreting QC results and drawing conclusions
about data validity.
Discussion: Our methods build upon existing guidance and years of practical experience collecting exposure data
and analyzing it in collaboration with contract and university laboratories, as well as the Centers for Disease Control
and Prevention. With real examples from our data, we demonstrate problems that would not have come to light
had we not engaged with our QC data and incorporated field QC samples in our study design. Our approach
focuses on descriptive analyses and data visualizations that have been compatible with diverse exposure studies
with sample sizes ranging from tens to hundreds of samples. Future work could incorporate additional statistically
grounded methods for larger datasets with more QC samples.
Conclusions: This guidance, along with example table shells, graphics, and some sample R code, provides a useful
set of tools for getting the best information from valuable environmental exposure datasets and enabling valid
comparison and synthesis of exposure data across studies.
Keywords: Exposure science, Environmental epidemiology, Environmental chemicals, Environmental monitoring,
Quality assurance/quality control (QA/QC), Data validation, Exposure measurement, Measurement error
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Background
Chemical measurements play a critical role in the study
of links between the environment and health, yet many
researchers in this field receive little if any training in
analytical chemistry. The growing interest in measuring
and evaluating health effects of co-exposure to a multi-
tude of chemicals [1, 2] makes this gap in training in-
creasingly problematic, as the task at hand becomes
ever-more complicated (i.e., analyzing for more and for
new chemicals of concern). If steps are not taken
throughout sample collection and analysis to minimize
and characterize likely sources of measurement error,
the impact on the interpretation of these valuable mea-
surements can vary along the spectrum from false nega-
tive to false positive, as we will illustrate with real
examples from our own data.
Some important considerations when measuring and
interpreting environmental chemical exposures have
been discussed in other peer-reviewed articles or official
guidance documents. For example, a recent document
from the Environmental Protection Agency (EPA) pro-
vides citizen scientists with guidance on how to develop
a field measurement program, including planning for the
collection of quality control (QC) samples [3]. The Cen-
ters for Disease Control and Prevention (CDC) also gives
guidance related to collection, storage and shipment of
biological samples for analysis of environmental chemi-
cals or nutritional factors [4]. To assess the quality of
already-collected data, LaKind et al. (2014) developed a
tool to evaluate epidemiologic studies that use biomoni-
toring data on short-lived chemicals, with a focus on
critical elements of study design such as choice of ana-
lytical and sampling methods [5]. The tool was recently
incorporated into “ExpoQual,” a framework for assessing
suitability of both measured and modeled exposure data
for a given use (“fit-for-purpose”) [6]. Other useful guid-
ance has been published, for example on automated
quality assurance/quality control (QA/QC) processes for
sensors collecting continuous streams of environmental
data [7] and for establishing an overall data management
plan, including documentation of metadata and strat-
egies for data storage [8].
Despite these helpful documents, there is still a lack of
readily accessible, practical guidance on how to interpret
and use the results of both field and laboratory QC checks
to qualify exposure datasets (i.e., flag results for certain
compounds or certain samples that are imprecise, esti-
mated, or potentially over- or under-reported) and this
gap is reflected in the environmental health literature.
While the vast majority of environmental health studies
report robust findings based on high quality measure-
ments, questions about measure validity have led to con-
fusion and lack of confidence in some topic areas. For
example, a number of studies have measured rapidly
metabolized chemicals such as phthalates and bisphenol A
(BPA) in blood or other non-urine matrices, despite the
fact that urine is the preferred matrix for these chemicals.
Phthalates and BPA are present at higher levels in urine
and, when the proper metabolites are measured, there is
less concern about contamination from external sources,
including contamination from plastics during specimen
collection [9].
More commonly, however, exposure studies simply do
not adequately report on QA/QC or describe how QC re-
sults informed reporting and interpretation of the data. In
the context of systematic review and weight of evidence
approaches, not reporting on QA/QC may result in a
study being given less weight. For example, the risk of bias
tool employed in case studies of the Navigation Guide for
Systematic Review includes reporting of certain QA/QC
results in its criteria for a “low risk of bias” rating (e.g., ref-
erence [10]). When we applied the Navigation Guide QA/
QC criterion to 30 studies of biological or environmental
measurements that we included in a recent review of en-
vironmental exposures and breast cancer [11], we found
that more than half either did not report QA/QC details
that were required for a “low risk of bias” assessment, or if
they did report QA/QC, did not interpret or use them ad-
equately to inform the analysis (e.g., reported poor preci-
sion but did not discuss how/whether this could affect
findings) (see Additional file 1 for details). Similarly, when
LaKind et al. applied their study quality assessment tool to
epidemiologic literature on BPA and neurodevelopmental
and respiratory health, they found that QA/QC issues re-
lated to contamination and analyte stability were not well-
reported [12]. Of note, several of the studies in our breast
cancer review that did not provide adequate QA/QC in-
formation had their samples analyzed at the CDC Envir-
onmental Health Laboratory. It is helpful to include
summaries of QA/QC assessments in published work
even if researchers are using a well-established lab, be-
cause this provides a useful standard for comparing QA/
QC in other studies.
Over many years of collecting and interpreting environ-
mental exposure data, we have developed a standard ap-
proach for (1) using field and laboratory QA/QC to
validate and qualify chemical measurement data for envir-
onmental samples and (2) presenting our QC findings in
our research publications (e.g., reference [13]). These
methods are based on data validation procedures from the
EPA, Army Corps of Engineers, and U.S. Geological Sur-
vey [14–17] and the guidance of the many experienced
chemists with whom we have collaborated. In this com-
mentary, we compile our methods into a practical guide,
focusing on how to use the information to make decisions
about data usability and how to make the information
transparent in publications. Our guide is organized in
three sections presenting questions to consider during
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study design, implementation, and data analysis. We de-
scribe key elements of QA/QC, including for assessing
precision, accuracy, and sample contamination, and we in-
clude suggested graphics (Additional files 2 and 4), and
table shells (Additional file 2) that clearly present QC data,
emphasizing how it may affect interpretation of study
measurements. Minimizing and characterizing potential
errors requires close collaboration between the re-
searchers who may have designed the study and plan to
analyze the data and the chemists performing the analysis,
so our guidance also includes example correspondence
(Additional file 2) to help establish this relationship at the
start of a project.
We present a detailed approach based on our own
studies, acknowledging that this is an example, not a
one-size-fits-all approach. Every study is unique and
some will require specialized quality assessment not cov-
ered here. Still, we anticipate that many environmental
health scientists will find this example to be a useful
framework for building their own processes.
Wrangling guide
Our guide is organized by a series of questions that we
ask when we start a new study and then again when we
receive measurement data from the lab. Key QA/QC
concepts are introduced in the Study Design section and
are most thoroughly addressed in sections about Study
Implementation and Data Interpretation.
Not every question is relevant to every study; for ex-
ample, researchers working with a lab to develop a new
analytical method will need to focus more on method
validation and quality control than those using a well-
established method and credentialed lab. Still, control-
ling for issues related to sample collection and transport
remain important in the latter scenario, as does variation
in method performance and/or sources of contamination
when samples are analyzed at the laboratory in multiple
batches. Our guidance is most relevant to targeted or-
ganic chemical analyses, which use liquid or gas chroma-
tography, often in combination with mass spectrometry,
to determine whether a pre-defined set of chemicals are
present in samples. QA/QC approaches for non-targeted
methods, where tentative identities are established by
matching to a library of mass spectra such as the Na-
tional Institute of Standards and Technology (NIST)
database [18], are addressed elsewhere [19].
This guide is not a set of rules, but rather establishes a
framework for evaluating and reporting QC data for
chemical measurements in environmental or biological
samples. While it may be most useful to environmental
health scientists who have little or no experience in ana-
lytical chemistry, we hope that researchers with a range
of experience will find it helpful to consult our approach
for evaluating and presenting QC data in publications.
Because the number of QC samples available is often
limited by budgetary constraints, many of the methods
we use rely on visualization and conservative action (i.e.,
removing chemicals from our dataset or qualifying their
interpretation unless there is evidence that the analytical
method was accurate and precise) rather than on statis-
tical methods. Whether statistical methods are incorpo-
rated or not, tabulating, visualizing, and communicating
about QA/QC for environmental exposure measure-
ments is important in order to reveal systematic error in
the laboratory [20] or in the field and support future use
of the data [6].
Study design
What can we measure and how?
One of our first priorities when designing a new study is
to consult with a chemist to establish an analyte list and
method for analysis.
Chemical identities Given the complexity of chemical
synonyms, it is helpful to be as specific as possible when
communicating about the chemicals to be analyzed. One
approach is to send the lab a list of the chemical names
(avoiding the use of trade names, which can be imprecise),
Chemical Abstracts Service (CAS) numbers, and configu-
rations (e.g., branched or linear, if relevant) of all desired
analytes (see Additional file 1 for example correspond-
ence). For biomonitoring, it is also important to determine
if the parent chemical or metabolites will be targeted.
Matrix Another consideration in developing the analyte
list is what type of samples are available (if working with
stored samples) or will be collected. As discussed previ-
ously, certain biological matrices are preferred over others
for measurement, depending on the chemicals (e.g., refer-
ence [9]). Matrix type is also relevant for environmental
samples; for example, physical chemical properties like the
octanol air partitioning coefficient inform whether an ana-
lyte is more likely to be found in air or dust [21].
Method The process of determining a final list of ana-
lytes will differ depending on whether the lab has an
established method or is developing a new method, and
whether it is targeted to a few chemicals with similar struc-
ture versus many chemicals with different properties (differ-
ent polarities, solubilities, etc.). Targeting a broad suite of
chemicals may limit the degree of precision and accuracy
that can be achieved for each individual chemical, and the
lab may need to invest substantial effort to develop a multi-
residue method – that is, a method that can analyze for
many chemicals at once – and determine a final list of target
chemicals with acceptable method performance. In any case,
a new method should be validated to characterize perform-
ance measures – precision, accuracy, expected quantitation
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and method detection limits, and the range of concentra-
tions that can be quantitated with demonstrated precision
and accuracy – before analyzing study samples. If the lab
already has an established method for the chemicals of inter-
est, the research team should review method performance
measures to ensure they are consistent with study
objectives.
Method – quantification The method of quantification
affects the types of QC data that are expected from the
lab. Three common approaches include external calibra-
tion, internal calibration and isotope dilution (a form of
internal calibration). External calibration, where the re-
sponse (i.e., chromatogram peak) from the sample is
compared to the response from calibration standards
containing known amounts of the analytes of interest, is
a simple method that can be used for a variety of differ-
ent analyses. However results can be influenced by inter-
ference from other chemicals present in the sample
matrix and resulting fluctuations in the analytical instru-
ment response [22]. With internal calibration, on the other
hand, one or more labeled compounds – either one of the
targeted analytes or a closely related compound – are
added to each of the samples just before they are injected
into the instrument for analysis and used to correct for
variation in the instrument response. The internal standard
must be similar to the target compounds in physical chem-
ical properties (e.g., a labeled polychlorinated biphenyl
should not be used to represent a brominated diphenyl
ether). Finally, for isotope dilution methods — which are
the most accurate — labeled isotopes for each of the target
compounds are added to samples prior to extraction. Add-
itional internal standards are added to the samples just
prior to injection to monitor loss of the labeled isotopes,
and the analytical software then corrects for loss during
sample extraction and for effects of the sample matrix (e.g.,
presence of other compounds in the sample that interfere
with the analysis) [22]. Many laboratories that analyze
chemical levels in blood, urine, or tissues — including the
CDC National Exposure Research Laboratory — use iso-
tope dilution quantification. However isotopically labeled
standards are not available for every compound and may be
cost prohibitive. If quantification is by internal or external
calibration, researchers will likely need to review and report
more extensive QC data from the lab compared to when
using isotope dilution, as discussed in Study Implementa-
tion: What QA/QC is needed?
Method – sensitivity Another important factor in
selecting a method is to make sure it is sensitive enough
to detect the anticipated concentrations in the field sam-
ples (samples submitted to the lab) down to levels that
are relevant to the research question. For example, com-
mercial labs measuring environmental chemicals may
establish reporting limits to meet the needs of occupa-
tional or regulatory safety compliance testing; these
limits may be much higher than levels that are meaning-
ful for research questions about general population ex-
posure and could result in most data being reported as
non-detect or qualified as estimated and imprecise. On
the other hand, lower reporting limits generally translate
to more expensive testing, so researchers have the op-
portunity to balance sensitivity and cost.
How to minimize sample contamination?
There are ample opportunities for sample contamination
during collection, storage, shipment and analysis, espe-
cially when targeting ubiquitous chemicals commonly
encountered in consumer products and in home and of-
fice furnishings or laboratory equipment. An important
aspect of method validation is to check for contamin-
ation of samples during field activities, from collection
containers, during transport and storage, and during la-
boratory extraction and analysis (see discussion of blanks
in the Study Implementation section). The CDC’s guid-
ance on sample collection and management identifies
some possible sources of contamination when analyzing
for common chemicals like plastics chemicals, antimi-
crobials and preservatives in blood or urine. Key consid-
erations, depending on the particular chemicals being
targeted, include selecting appropriate collection con-
tainers (e.g. glass containers if analyzing for plastics che-
micals), avoiding the use of urine preservatives (e.g.,
when analyzing for parabens, BPA), and providing ad-
equate instructions to participants collecting their own
samples (e.g., avoid using antimicrobial soaps or wipes
during collection) [4]. As noted previously, contamin-
ation can also be minimized in biomonitoring of some
chemicals by measuring a metabolite rather than parent
chemical, and possibly by measuring a conjugated rather
than free form of the metabolite [9]. In some cases, the
lab may need to pre-screen collection containers or
other sampling materials to see if they contain any target
chemicals. For example, when we used polyurethane
foam (PUF) sorbent to collect air samples for analysis of
flame retardants, plastics chemicals and preservatives,
we asked the lab to pre-screen the PUF matrix for target
analytes. Another important precaution was to ship the
samplers wrapped in aluminum foil that had been baked
in a muffle furnace to ensure it was clean and uncoated.
How will the lab report the data?
Three key elements of data typically reported by the lab
are the identity of the chemical, the reporting limit for
each chemical and sample, and how much of each
chemical is present in each sample. Sometimes an add-
itional measure is needed to normalize mass of chemical
per sample, for example, grams of urinary creatinine,
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urine specific gravity, grams of serum lipid, or cubic me-
ters of air (see reference [5] for discussion of issues re-
lated to matrix adjustment and presentation of
measurements).
Chemical identities It is helpful to request in advance that
the lab report CAS numbers and configurations (if relevant)
along with chemical names (see Additional files 2 and 3 for
example reporting requests).
Reporting limits Common terms used by laboratories
to discuss reporting limits include instrument detection
limit (IDL), method detection limit (MDL) and limit of
quantitation (LOQ). The IDL and MDL are both related
to the level of an analyte that can be detected with confi-
dence that it is truly present. The IDL captures the smal-
lest true signal (change in instrument response when an
analyte is present) that can be distinguished from back-
ground noise (variation in the instrument response to
blank samples), while the MDL takes into account add-
itional sources of error introduced during sample prepar-
ation (e.g., the extraction process, possible concentration
or dilution of samples) and thus is higher than the IDL.
The MDL is also often referred to as the limit of detection
(LOD) or detection limit (DL). The LOQ, on the other
hand, describes the lowest mass or concentration that can
be detected with confidence in the amount detected. The
reporting limit (RL) or method reporting limit (MRL),
which is either the lowest value that the lab will report or
the lowest value that the lab will report without flagging
the data as estimated, is often (but not always) the same as
the quantitation limit or LOQ.
Before submitting samples for analysis, it is helpful to
find out (1) the methods and terminology that the la-
boratory will use to describe reporting limits (LOD,
LOQ, etc.) and (2) whether reporting limits will be con-
sistent within a chemical or whether limits could vary
between samples or batches. Equally critical is to clarify
how the lab will report non-detects. Several different
values could appear in the amount or concentration
fields for non-detects, including but not limited to zer-
oes, the detection limit, the reporting limit or “ND.”
Amount Another important point to discuss in advance
with the laboratory is how they will report values for
compounds with a confirmed identity but measured at
levels below what can be accurately quantitated. For ex-
ample, when measuring chemicals of emerging interest,
we ask laboratories to report estimated values below the
RL and we flag them during data analysis. This practice
has some limitations [23] but is preferable to falsely re-
ducing variance in the dataset by treating estimated
values below the RL as equivalent to non-detects below
the detection limit. Non-detects can present significant
data analysis challenges, and while a discussion of the
best available methods and the problems with common
approaches such as substituting the RL, RL/2 or zero for
non-detects is beyond the scope of this commentary, it
is a critical issue and we refer the reader to several help-
ful resources [23–26]. Reporting estimated values is not
standard practice for many laboratories, so it is import-
ant to raise this issue early on (see Additional file 2 for
example correspondence). If the lab reports data quali-
fier flags, it may be necessary to clarify the interpretation
of those flags, including but not limited to which flags
distinguish non-detects from detects above the MRL and
estimated values. It is best not to make assumptions.
Study implementation
What QA/QC is needed?
QA/QC occurs both inside and outside the analytical la-
boratory (see Table 1). Field QC samples, namely blanks
and duplicates, capture the sum of contamination and
measurement error from collection, storage, transport,
and laboratory sources. We base the number of QC
samples we collect in the field on budget and our sample
size, generally aiming for at least 20% QC samples (e.g.,
if collecting 80 field samples then collect 16 field QC
samples), though a higher percentage is needed in small
studies. Lab analysts should be blinded to the identity of
field QC samples whenever possible. Maintaining blind-
ing can be challenging, so it is worth putting some
thought into sample names (e.g., QC samples should not
have obviously different IDs than other samples, should
not be labeled with a “D” for duplicate or “B” for blank).
Logs retained at the site must contain sufficient informa-
tion to allow the data analysts to identify field QC sam-
ples and sample types.
QC samples prepared in the lab can include spiked
samples or certified reference materials (CRMs) for tar-
get chemicals to evaluate the accuracy of the analytical
method, surrogate compounds added to field samples to
estimate recovery during extraction and analysis, and
blanks to assess contamination with target chemicals
from some source in the laboratory. While laboratories
generally conduct rigorous review of their own QC data,
considering lab and field QC together can help to iden-
tify specific sources of contamination, imprecision, and
systematic error, so we typically request to review the
lab’s raw QC data in conjunction with the field QC data.
Spiked samples and certified reference material
Spiked samples and CRMs establish the accuracy of
the method by assessing the recoveries of known
amounts of each target chemical from a clean or
representative matrix. A CRM is a matrix compar-
able to that used for sampling (e.g., drinking water)
that has been certified to contain a specific amount
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Table 1 Summary of QC sample types, interpretation, and possible actions
QA/QC
Concept
Measure Interpretation Possible Actions
Accuracy Lab control sample recoveries
and/or matrix spike recoveries
Certified reference material
Isotope dilution quantification
Measure of whether the analytical
method produces accurate
quantification for each compound.
Matrix spike recovery evaluates
matrix effects on accuracy, such
as interferences.
Isotope dilution is the most rigorous
approach to generating accurate
measurements in biomonitoring.
• Drop compounds with inaccurate
quantification from the data analysis,
discuss with lab whether improvements
can be made for future analyses.
• If problems are modest and batch-specific,
include batch as a covariate in regression
model.
Extraction
efficiency
Surrogate spike recovery in
each sample
Measure – for each field sample -
of whether the chemical is extracted
completely from the sample matrix,
(e.g., blood, dust).
Isotope dilution approaches capture
and correct for differences in extraction
efficiency.
• Consider dropping samples with poor
surrogate recovery from data analysis.
• Consider applying a surrogate correction
factor (1/fraction recovery) if the recovery
is consistent (± 15–20% in standard
deviation).
Detection limit Level above which the lab can detect
with confidence that the analyte is
present in the sample.
Common terms include:
Instrument detection limit (IDL),
Detection limit (DL), Method detection
limit (MDL), Limit of detection (LOD)
• See Method Reporting Limit.
Quantitation
limit
Level above which the lab can quantify
with confidence the amount of chemical
in the sample.
Common terms include:
Practical quantitation limit (PQL), Limit of
quantitation (LOQ), Laboratory quantitation
level (LQL), Contract required quantitation
limit (CRQL)
• See Method Reporting Limit.
Method
Reporting Limit
(MRL)
Levels detected in blanks
(lab-blind field blanks, solvent
blanks, matrix blanks, storage
blanks, other types)
Level above which the researcher is
confident that the reported chemical
measurement reflects a signal from
the media sampled, considering all
sources of measurement error,
especially potential contamination
during sample collection and handling
as well as in the laboratory.
• Determine MRL by comparing
the lab limit (quantitation limit,
unless not reported, in which
case detection limit) to the levels
in the blanks for each compound.
• Qualify reported values below the
MRL as “estimated”.
Potential
contamination /
Analytical bias
Levels detected in blanks
(lab-blind field blanks, solvent
blanks, matrix blanks, storage
blanks, other types)
Measure of confidence in accuracy
of values reported above the MRL.
• If evidence of contamination, consider
dropping a compound or dropping
results for a compound in a particular
batch.
• Identify source of contamination
(e.g., lab vs field equipment) to
inform future work.
• For compounds with consistent
contamination in blanks, researchers
may correct field sample quantity by
subtracting the amount attributed to
contamination. This is most important
when contamination is significant
relative to sample values (e.g., > 10%)
and for comparisons with external data.
Precision Relative percent difference (RPD) for
side-by-side duplicate samples (lab-blind)
or split samples (lab-blind if possible)
A measure of reproducibility of field
measurements, including analytical
variability and sampling variability.
• Flag compounds with > 30% RPD.
• Consider precision in combination with
other QA/QC when deciding to qualify
results.
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of analyte with a well-characterized uncertainty. If
CRMs aren’t available, the laboratory can prepare labora-
tory control samples (LCSs) by spiking known amounts of
target chemicals into a clean sample of the matrix of inter-
est, such as a dust wipe, air sampler, purified water or syn-
thetic urine or blood that has been analyzed and shown to
be free of the analytes of interest, or to contain a consistent
amount of analytes of interest that can be subtracted from
the amounts measured in the spiked sample to calculate a
percent recovery. The LCS or CRM – at least 1 per analyt-
ical batch – is run through the same sample preparation,
extraction, and analysis as the field samples to capture the
accuracy of the complete method; calculating the percent
of the known/spiked amount recovered for each analyte
tells us whether the method is accurate in the matrix.
Another type of spiked sample, called a matrix spike,
can be used to check the extraction efficiency for a com-
plex sampling matrix that may interfere with the ana-
lysis. These samples are typically included if there is
concern about interference from the sampling matrix,
for example, with house dust, soil or sediment samples,
consumer products, or biological samples like blood. In-
stead of recovery from a clean matrix, these QC checks
capture recovery from a representative field sample.
Here the “matrix” refers to all elements of the sample
other than the targeted analytes; this includes the sam-
pling medium (e.g., dust, PUF, foam) itself as well as any
other chemicals present in the sample that might inter-
fere with measurement of target chemicals. A matrix
spike can be created, for example, by splitting a repre-
sentative sample collected in the field and spiking the
target analytes into one half prior to extraction and ana-
lysis. The recovery of spiked analyte is determined as the
amount measured in the spiked sample minus the
amount measured in the non-spiked sample divided by
the spike amount. A limitation of this approach is that
the analytes are spiked in an already dissolved state, so it
is possible that the analytes in the environmental matrix
would not be extracted as readily from the matrix as the
spiked chemicals. Thus, the true extraction efficiency
may be lower than represented by the matrix spike.
For newly developed methods where performance is not
characterized, we request results for all recoveries of spiked
samples and/or CRMs so that we can perform visual checks
that have at times revealed systematic problems with the
analytical method that were not noted by the lab (see Data
Interpretation: Is the method accurate? for discussion). For
well-established methods, and particularly when isotope di-
lution quantification is used, it is sufficient to request a
table summarizing the spike recovery or CRM recovery re-
sults (by batch, if relevant) for reporting in publications.
Surrogate recovery standards Whereas recoveries from
LCSs, matrix spikes and/or CRMs tell us about the
performance of the method in a clean or representative
matrix, surrogate compounds are used to evaluate recov-
eries from individual samples. Recoveries of surrogate
compounds can help identify any individual samples that
may have inaccurate quantification, for example due to
extraction errors or chemical interferences. Surrogates,
like internal standards, are spiked into each sample,
however surrogates are added prior to sample extraction
to assess the efficiency of this process. Internal stan-
dards, on the other hand, are added after extraction, just
prior to injection into the chromatographic system, to
account for matrix effects and other variation in the in-
strument response during analysis. The ideal surrogate is
a chemical that is not typically present in the environ-
ment but that is representative of the physical and
chemical properties of target analytes [16]. It is best to
have a representative surrogate for each individual
chemical, though when analyzing for numerous chemi-
cals at once with multi-residue methods, cost and time
restraints may result in one or a few surrogates being se-
lected to represent a class of compounds. In this case it
is critical that the lab selects an appropriate surrogate.
For analyses using external or internal calibration, we
ask the lab to provide us with the recovery results for
each surrogate in each sample, so that we can flag any
samples or compounds that might have had extraction
problems. However if the lab uses isotope dilution quan-
tification, we are less concerned about obtaining this
raw data from the laboratory given that the reported re-
sults are already automatically corrected for extraction
and matrix effects.
Blanks Collecting and preparing several types of blank
samples helps us to distinguish sources of contamin-
ation. Laboratory blanks alert us to possible contamin-
ation originating in the lab. These blanks can capture
contamination during sample extraction (solvent blanks),
from reagents and other materials used in the analytical
method (solvent method blanks) or from “typical” back-
ground levels of target analytes present in the sampling
matrix (matrix blanks). Field blanks, on the other hand,
capture all possible contamination during sample collec-
tion and analysis. Field blanks are clean samples (e.g.,
distilled water, air sampling cartridge detached from
pump immediately following calibration) that are trans-
ported to the sampling location and exposed to all of the
same conditions as the real samples (e.g., the sampler is
opened, if applicable) except the actual collection
process. We aim for at least 10% of our samples to be
field blanks, with an absolute minimum of 3 field blanks.
Unfortunately, in some cases there aren’t good options
for representative field blanks. For example field blanks
can be created for biomonitoring programs by taking
empty collection containers into the field and using
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purified water or synthetic urine or blood to create a
blank [4]. However, important short-comings of this ap-
proach are that (1) it is difficult to capture contamin-
ation that can be introduced by sample collection
materials such as needles and plastic tubing used to col-
lect blood, (2) water may not perform the same as urine
or blood in the extraction and analysis, and (3) the lab
will likely be able to identify the field blanks. Similarly, it
is difficult to maintain lab blinding when using a “clean”
matrix like vacuumed quartz sand as a field blank for
vacuumed house dust.
Duplicates Collecting side-by-side duplicate samples in
the field helps assess the precision of both the sample
collection and analytical methods. Duplicate samples can
also be created by collecting a single sample and splitting
it prior to analysis, which is the only option for biological
samples; however, this method only captures the precision
of the analysis process [14, 17] and could lead to un-
blinding of the lab analyst, if for example the split samples
are noticeably smaller than others. When planning for du-
plicate collection, the best practice is to label these sam-
ples so that the lab analyst is blinded to duplicate pairs
(i.e., use different Sample IDs for the two samples). Ideally,
researchers should plan to collect or create (that is, split)
one duplicate pair per every 10–20 samples collected, and
spread duplicate pairs across analytical batches.
Analytical batches Analytical performance can shift
over time and even between multiple extractions or in-
strument runs within a short time window. Laboratories
often analyze samples in multiple batches, that is, sets of
field samples and associated laboratory QC samples that
are analyzed together in one analytical run. The time be-
tween batches can vary from days to months or even
years, though ideally this time span is minimized in
order to maintain consistent equipment and procedures
throughout the study.
Two approaches help address batch-to-batch variability:
(1) randomizing participant samples between batches by
specifying the order and grouping of samples (and blind
field QC samples) when submitting samples to the lab (this
may require corresponding with the lab to determine the
batch size in advance), and (2) running CRMs – such as
standard reference material (SRM) from NIST [27] – in
each batch of samples in order to characterize drift. When
CRMs are not available, another option is for the researcher
to prepare identical/split reference samples. We have done
this, for example, by pooling together several urine speci-
mens and making many aliquots of the pool, then including
1–2 blinded samples from this pool with each set of sam-
ples we send to the lab. If the laboratory analysis is per-
formed in multiple batches, all QC elements should be
examined on a batch-specific basis. Not every laboratory
will specify whether or not samples were analyzed in
batches; it is a good idea to request that a variable for batch
be included in the results report.
In Additional files 2 and 3, we provide example corres-
pondence for requesting QC data and consistent format-
ting from the lab.
Data interpretation
What was measured?
Chemical identities No amount of QA/QC can save a
dataset from basic misunderstandings about what is be-
ing reported. After receiving data, it is helpful to ask the
chemists to double check the analyte list (chemical
name, CAS, isomer details) against the list of standards
used in the analysis, particularly if this information was
not included in the report from the lab. It is worthwhile
to make this verification even when chemical identities
were specified in advance of the analysis as it is possible
that the standard used for analysis was slightly different
than planned. Only through this process, for example,
did we discover that a lab had accidentally purchased a
standard for 2,2,4-trimethyl-1,3-pentanediol isobutyrate
rather than 2,2,4-trimethyl-1,3-pentanediol diisobutyrate
(two different chemicals).
Table 2 summarizes some steps for getting acquainted
with a new dataset received from the lab. We have also
published sample R code on GitHub that may be helpful
for getting acquainted with a new dataset, including exam-
ining trends in QC and field samples over time [28].
Were there trends over time?
Analytical batches Examining results by batch or even
by sample run order can reveal trends in QC samples
over time, identifying systematic laboratory errors that
Table 2 Get acquainted with your data
1. Verify chemical identities.
○ Check CAS number, chemical name, isomer type of reported analytes
vs. analytical standards purchased by lab (see Additional file 2 for
example correspondence).
2. Count (overall and by batch) the number of:
○ “Real” samples – compare these to the chain of custody that lists
the samples submitted for analysis to make sure all submitted
samples were analyzed
○ Lab control and/or matrix spike recoveries
○ Reference samples (e.g., CRMs)
○ Surrogate spike recoveries
○ Blanks (solvent method, field, matrix, other)
○ Duplicates
3. Examine any data qualifier flags reported by the lab and make sure
interpretation is clear.
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may be missed by summary statistics or visualizations
[20]. Shifts in method performance over time may require
batch-specific corrections or dropping or flagging data
from certain batches. Notably, a trend in QC sample re-
sults over time can be problematic even if they remain
within the acceptable limits established by the lab. In our
own work, for example, examining our data by analytical
batch revealed an upward trend in sample-specific detec-
tion limits for some analytes, such that detection limits in
later batches were within the range of sample results from
earlier batches (Fig. 1). The detection limits in the later
batches still met the specifications of our contract with
the lab, but it was clear that we would not be able to com-
pare results in the latter two batches to those in the first
three. We showed the plot in Fig. 1 to the lab and they
agreed to re-analyze the samples in the later batches,
which resulted in more consistent detection limits.
Is the method accurate?
Spiked samples and certified reference material
Table 3 outlines our approach for analyzing LCS or
matrix spike recovery or CRM data. The approach is similar
for all of these samples. However one distinction is that if
Fig. 1 Visualizing urine sample results by analytical batch (data not
yet published) revealed that sample-specific detection limits in later
batches were higher and in the range of sample results in previous
batches. After discussing with the laboratory, samples in later
batches were re-analyzed to achieve lower detection limits
Table 3 Spiked samples and certified reference material
Approach (see Additional file 4 for example of this approach with real
data):
1. Summarize percent recoveries for each chemical across analytical
batches and flag those chemicals with average recoveries outside of a
pre-established acceptable range.
□ We typically apply an acceptable range of 50–150% recovery for
most environmental samples, particularly when we are analyzing for
new chemicals or combinations of chemicals for which methods are
not well-established. For well-established methods, a more
conservative range – 80-120% recovery – is appropriate.
2. Visualize percent recoveries for each chemical across analytical
batches to assess consistency.
□ If recoveries for a particular chemical or chemicals are consistently
out of range (> 150% or < 50%) across multiple batches, this should
be discussed with the laboratory analyst.
○ If the laboratory analyst agrees that the method was not
successful, we drop the chemical(s) from our dataset. We do not
report values or include such chemicals in any data analyses.
○ If the laboratory analyst can explain the reason for consistent
high or low recoveries and has confidence in the ranking and
relative values of the reported sample data, the reported values can
be used for many data analyses, but it will be difficult to compare
with levels from another study.
□ If recoveries from one or a few batches are out of range, we are
concerned that results in those batches might be over/under-
estimated compared to the rest. One way to investigate this concern
is to look for corresponding systematic differences in sample data
(see Additional file 4: Figure S3).
○ If field samples have been randomized into batches, we check if
the variation in sample results correlates with spiked sample or
CRM recoveries by batch. Note: we still go through this step even if
we were not able to randomize field samples, but in this case it
can be very challenging to distinguish systematic analytical
variation from other possible sources of variation in sample results
between batches (e.g., if samples in different batches were also
collected during different seasons).
▪ If there are systematic differences (e.g., the sample results for a
chemical are higher in the batch where the spike or CRM recovery
was high, or if only one batch, the sample results for a chemical
with high spike or CRM recovery are much higher than previously
reported levels), we consider dropping the chemical results from
the affected batches from the dataset. If an identical/split reference
sample was analyzed in each batch, these results can also be
helpful to resolve questions about whether and how to use the
data in this case.
▪ If there are no obvious systematic differences, we keep the
chemical in our dataset, but flag the results for that chemical in the
batch with the out-of-range spiked sample or CRM recovery.
Reporting:
□ We note in summary statistics when the average spiked sample or
CRM recovery for a particular chemical was out of range.
□ We note whether levels in our study might be systematically over- or
under-reported (i.e., because of consistent high or low spiked sample or
CRM recoveries). We especially note this if comparing to levels from
another study.
□ For chemicals with low/high recoveries in certain batches, we may
perform sensitivity analyses – for example, by including lab batch as a
covariate in regression analyses, though this can be challenging for
small datasets.
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LCS recovery and other QC measures, such as lab blanks
(matrix, solvent method, or other) are acceptable, a poor
matrix spike recovery (higher or lower than acceptable
bounds) can alert chemists to interferences from matrix ef-
fects, and suggest steps to address this such as matrix-
matched calibration [17]. We typically only use data for ana-
lytes that have average LCS, matrix spike and/or CRM recov-
eries between 50 and 150%, though this decision criterion
can be adjusted based on the needs of the project. If we do
retain data for chemicals with spike or CRM recoveries out-
side of this acceptable range, we note in publications that
concentrations in our data may be under- or over-reported.
Figure 2 illustrates a case from our own data where the
laboratory reported that 1,2,5,6,9,10-Hexabromocyclodode-
cane (HBCD), a brominated flame retardant, was mostly
“not detected,” but the LCS recoveries, which ranged from
− 2 to 1670% and averaged about 750%, indicated that the
method was not able to accurately quantify this chemical.
We removed this compound from our dataset and did not
report on it. Examining spike recoveries thus prevents us
from reporting a chemical as “not detected,” or from
reporting an unreliable detect, if the analytical method is
not performing accurately for that compound.
A summary of the recovery information should be in-
cluded in the peer-reviewed manuscript to demonstrate
accuracy. See Additional file 2: Tables S1-S2 and Figure
S1 for an example of how to present this information.
Were there problems with certain samples?
Surrogate recovery standards When isotope dilution
quantitation with automatic recovery correction is not
employed, we review the surrogate recovery standard
data for each individual sample, generally considering
50–150% recovery to be acceptable. Interpretation of an
out-of-range surrogate recovery depends both on its direc-
tion and on the levels of the associated analytes (i.e., those
represented by the surrogate compound) measured in the
sample. In samples with low surrogate recoveries, the
concern is that if similar target analytes are present in the
sample, the measurements will be underestimated/biased
low. For samples with high surrogate recoveries, on the other
hand, we can be confident that similar target compounds
should be detected if present, but the amount may be
overestimated or biased high. If surrogate recoveries are out-
of-range in all samples, and particularly if they are also out-
of-range in blank samples, this is likely indicative of a
broader problem with the analytical method [16, 29]. Table 4
outlines our approach for analyzing surrogate recovery data.
Figure 3 shows an example where our examination of
surrogate recoveries on a batch-specific basis indicated
trends in the recoveries over time, even though most
remained within the generally acceptable range (50–
150%). This plot led to a discussion with the lab analyst,
who suggested that stock solutions for surrogate com-
pounds may have concentrated over time as solvent
evaporated, until a new stock solution was prepared for
the last batch. On the advice of the lab analyst, we
looked at trends in the “spike check” – solvent that is
spiked with target analytes but not extracted or concen-
trated – sample recoveries. Spike check recoveries indi-
cated good reproducibility, giving us confidence that the
drift in surrogate recoveries did not reflect changes in
instrument calibration over time.
Fig. 2 a Results for flame retardant HBCD measured in air samples collected in 105 homes. All but three samples were non-detects (open circles).
Samples were analyzed in six different analytical batches. b Summary of laboratory control spike recovery data for HBCD across the six analytical
batches shows very poor accuracy and indicates no confidence for this analyte in the indoor air samples
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Is there evidence of contamination or analytical bias?
Blanks Once we have determined that we can accurately
measure the target analytes in our sampling matrix, the
next step is to ensure that we are confident about whether
those target analytes came from the study site or participant
– or from somewhere else. Table 5 outlines our approach
to reviewing data from blank samples. When it is not
straight forward to collect field blanks (e.g., for blood sam-
ples), any assessment of contamination introduced from
Table 4 Surrogates
Approach (see Additional file 4 for example of this approach with real
data):
1. Count high and low recoveries for each surrogate chemical across
analytical batches.
□ We typically apply an acceptable range of 50–150% recovery for most
environmental samples, particularly when we are analyzing for new
chemicals or combinations of chemicals for which methods are not
well-established. For well-established methods, a more conservative
range – 80-120% recovery – would be appropriate.
2. Identify any sample where all surrogate recoveries were low (e.g., <
50%). This suggests a potential problem with the extraction for that
sample.
□ Discuss with lab analyst. Consider dropping sample.
3. Visualize surrogate recoveries for QC samples (lab blanks, lab control or
matrix spikes) across analytical batches. See Additional file 4: Figure S4
for an example.
□ If these recoveries are out of range, this suggests a larger problem
with the analytical method rather than with particular samples.
Summarize information about the surrogate recoveries in the QC
samples as well as lab control or matrix spike recoveries for the
associated chemicals and discuss with lab analyst.
4. Visualize percent recoveries across all samples for each surrogate, by
analytical batch. See Additional file 4: Figure S6 for an example.
□ Note any trends (upward or downward) in the distribution of
surrogate recoveries across batches. Such trends should be discussed
with the laboratory analyst, even if all recoveries are in the 50–150%
acceptable range (see Fig. 3 for an example).
□ If the surrogate is a deuterated version of one of the target
chemicals, it can be helpful to compare a plot of the surrogate
recoveries by batch to the sample data for the corresponding un-
deuterated target chemical by batch. We would be concerned – and
would seek guidance from the lab analyst – if we saw a trend for the
target chemical results that matched the trend in the surrogate
recoveries.
□ Note if many surrogate recoveries (e.g., more than half) are out of
range in a particular lab batch. If yes, flag the results in that batch for
the chemical(s) represented by that surrogate.
5. Visualize sample results flagged by surrogate recoveries. For each
individual sample with an out-of-range recovery for a surrogate, flag the
results for the chemical(s) associated with that surrogate. Plot all sample
data with indicators (e.g., different colors) for whether the representative
surrogate for each sample was out of range. See Additional file 4: Figure
S7A-D for an example.
□ Note whether samples with high surrogate recoveries consistently
have the highest results for the associated chemical(s).
○ If yes, we would be concerned that samples with high recoveries
are all overestimated. Discuss with lab analyst. Consider applying a
surrogate correction factor to sample results (multiplying by 1/
fraction recovery).
□ Note whether samples with low surrogate recoveries were
consistently non-detects or very low-level detects for the associated
chemical(s).
○ If yes, we would be concerned that samples with low recoveries
are all underestimated. Discuss with lab analyst. Note in
publications that levels and detection frequencies for associated
chemicals might be underestimated.
Reporting:
□ In summary statistics, we note whether any maximum value is from
a sample associated with a high (> 150%) surrogate recovery and
note that in this case the maximum might be overestimated.
Table 4 Surrogates (Continued)
Similarly, if 100% of samples are detects, we also flag the minimum
value if it is from a sample associated with a low (< 50%) recovery
and note that in this case the minimum might be underestimated.
□ For any statistical analyses, if possible (i.e., if large enough dataset)
we run sensitivity analyses:
○ Excluding samples with out-of-range surrogate recoveries.
○ Controlling for lab batch, if surrogates were problematic for a
particular batch.
Fig. 3 In this example from our data, recoveries of surrogate d4-di-
n-butyl-phthalate from air samples showed notable upward and
downward trends over time, despite largely staying within the 50–
150% acceptable bounds. Here we were examining surrogate
recoveries in batches of samples from different studies analyzed at
the same laboratory. The last two batches (Sept 2014 and May 2015)
were from the same study but collected approximately a year apart
per the study design
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sampling (e.g., pre-screening of collection materials) should
be thoroughly described and limitations acknowledged.
Figure 4 illustrates an example from our study com-
paring levels of chemicals in air in college dorm rooms
before and after students moved in (data not yet pub-
lished) where field blanks proved particularly crucial.
Our first look at the sample data suggested that bis(2-
ethylhexyl) phthalate (DEHP), a chemical commonly
used in plastics, was present at notably higher levels after
students moved in. However, upon further review, we
found that DEHP levels in the field blanks were also
higher and in the range of the sample data at the post-
compared to pre-occupancy time point. At the same
time, levels of DEHP in the laboratory blanks (matrix
and solvent method) were not elevated. A conversation
with the lab revealed that different plastic bags may have
been used to transport samples during the later round of
sampling (i.e., the post-occupancy sampling). These bags
may have contained higher levels of DEHP.
Typically, we use blanks to qualify values rather than re-
move measurements from our data. Specifically, we use de-
tected values in field blanks and sometimes other blanks
(see Table 6) as a basis to qualify data by raising the method
reporting limit (MRL), flagging low values as estimated,
until we feel confident in the levels we’re reporting. Values
reported by the lab but below the MRL are considered
estimated (see Fig. 5 for example of graphical presentation
distinguishing estimated detects below the MRL from true
detects above the MRL). In the example of the potentially
DEHP-contaminated plastic bags used to transport sam-
ples, however, we decided not to report DEHP levels for
the post-occupancy samples, given the evidence that con-
tamination might have significantly biased the results in
that batch. Unexpected findings, such as a chemical or che-
micals detected at much higher levels in a lab blank
(matrix, solvent method, or other) than in the field blanks,
warrant further investigation. In this case, we might suspect
that the lab blank was contaminated by another sample;
examining the sample run order (which must be requested
from the lab, see example correspondence in Additional file
2) could shed light on whether a very high sample was run
directly before the lab blank.
After we establish the MRL for chemicals that are de-
tected in blanks, we are confident that levels in samples
above that value are true detects and that they are cor-
rectly ranked, but there may still be concern about con-
sistent bias in the actual numeric values being reported,
Table 5 Get acquainted with blanks
Approach (see Additional file 4 for example of this approach with real
data):
1. Summarize results across all chemicals by blank type (e.g., field blank,
solvent method blank, matrix blank, etc.), with non-detects set to zero.
For chemicals with no detects in blanks, the MRL will equal the lab
reporting limit and none of the subsequent steps in Tables 6 or 7 are
needed.
For chemicals detected in blanks:
2. Visualize levels in blanks by blank type. Set non-detects to ½ lab
reporting limit and plot by analytical batch.
□ Consider whether blank detects are consistent across batches. Note
whether detects seem to occur mostly in one type of blank which
could indicate a source of contamination in the lab or field.
○ If a particular source is suspected, we investigate (talk to lab, look
at field logs, etc.).
3. Visualize levels in blanks by blank type along with field samples by
analytical batch. Set non-detects to ½ lab reporting limit.
□ Note whether blanks are in range of the samples.
□ If field samples have been randomized into batches, check if
variation in sample results correlates with blank results by batch.
Note: we still go through this step even when we were not able to
randomize field samples, but it is more challenging to distinguish
whether contamination is driving differences in sample results in a
particular batch or whether other explanations are more likely (e.g., all
samples in one batch were collected in a different season or from a
particular study site). Fig. 4 Phthalate DEHP measured in air in college dorm rooms
before and after occupancy (data not yet published). Levels in our
samples (purple dots) were higher post- compared to pre-
occupancy, but this plot revealed that levels in field blanks (blue
dots) were also higher post- compared to pre-occupancy and within
the range of field samples. We also saw a matrix blank (green dot)
well within the range of the field samples in the pre-occupancy
batch. These data suggest DEHP contamination in both batches; for
the post-occupancy batch, we hypothesized this might have come
from the plastic bags in which the samplers were shipped. We will
not report results for this chemical from this study, given the
evidence of contamination. LLOQ = Lower Limit of Quantitation
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both from contamination in the field or lab or from bias
in the analytical method. Consistent bias in levels would
not be a major concern for ranking individual exposure or
comparing groups within a study but is misleading when
comparing to levels reported in other studies. For each
chemical, we check for evidence of consistent bias across
many blanks and correct concentrations reported in sum-
mary tables in our papers to reduce this bias (see Table 7).
How precise are these measurements?
Duplicates Duplicate samples indicate whether variation
in our data is explained by imprecision. If duplicate
Table 6 Consider Raising Method Reporting Limits (MRLs)
Approach (see Additional file 4 for example of this approach with real
data):
1A. For chemicals not detected in blanks, the MRL is equal to the
laboratory reporting limit.
1B. For each chemical detected in blanks, if there are detects in blanks in
all batches, establish the MRL as follows (otherwise proceed to 1C):
□ Compare the lab’s reporting limit to the 90th percentile of field
blanks (computed with non-detects set to ½ lab’s reporting limit). The
higher value is the new MRL.
○ However, if we observe many detects in other types of blanks
(e.g., matrix, solvent), we consider determining the MRL by
comparing the lab’s reporting limit to the 90th percentile of ALL
blanks (computed with non-detects set to ½ lab’s reporting limit).
The higher value is the new MRL.
○ It can be helpful here to plot sample data with different possible
MRLs to gain understanding of precisely what is being achieved by
raising the MRL (i.e., are we successfully flagging data that we are
not confident in and at the same time leaving data in which we
have confidence unqualified?). See Additional file 4: Figure S9, for
an example of this type of plot.
*Note*: we use the 90th percentile of the blanks rather than using
the maximum value or the mean because the 90th percentile is less
sensitive to extreme values and can be estimated for data that are
not normally distributed. However if the overall study is small (e.g., in
our practice, when we have < 5 blanks), we set the MRL equal to the
maximum blank mass.
1C. For each chemical detected in blanks, if detects in blanks are
clustered in one or a few batches:
□ If just one extremely problematic batch, consider dropping the
sample data from that batch.
□ If multiple field blanks were run in each batch, can consider
determining MRL as above but on a batch-specific basis.
○ In this case, the way to proceed will very much be a judgment
call. Spend time with the data considering various approaches.
□ Data from reference material and duplicate samples can be helpful
in deciding which data points should be qualified because they are
“in the noise.”
2. After determining the MRL, we flag each sample result as follows:
□ 0 flag = measurement reported by the lab as “non-detect”
□ 0.5 flag =measurement falls below the MRL. These are considered
“estimated detects”
□ 1 flag = measurement falls above the MRL. These are considered
“true detects”
Note that our data qualifier flags may differ from those used by others.
For example, NHANES flags non-detects with a “1” and detects with a
“0.”
3. Normalize MRL.
□ If the MRL is determined on a mass basis but sample results are
normalized by some factor, such as sample volume, we compute a
sample-specific concentration-based MRL by dividing the mass-based
MRL by the sample volume.
Reporting:
□ We do not count estimated values (0.5 flags) as detects when reporting
%>MRL. We do not use estimated detects to calculate summary statistics
such as percentiles (see Table shell S2 in Additional file 2).
□ In summary statistics, we identify any chemicals with greater than
50% estimated detects and add a footnote: “Imprecise quantification
for more than 50% of detected values”.
Table 6 Consider Raising Method Reporting Limits (MRLs)
(Continued)
□ Graphical presentations should distinguish estimated from true
detects (e.g., by plotting as different shapes, see Fig. 5).
□ For reporting in tables, we use median sample volume across
samples to convert mass-based MRL to a single concentration-based
MRL for each chemical, if applicable.
□ There are different approaches for incorporating estimated or 0.5
flagged values in statistical analyses, including performing analyses
weighted by estimates of the measurement precision below the MRL,
or using censored regression methods [23]. However any approach
that incorporates estimated values is preferable to procedures that
substitute with the DL, ½ DL, zero, or remove these values, a practice
which can introduce bias [25].
Fig. 5 Example of graphical presentation distinguishing true,
estimated, and non-detects. MRL = Method Reporting Limit
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samples have high reproducibility, meaning that the rela-
tive percent difference between measurements in dupli-
cate samples is less than 30%, it adds to confidence in
the field sample results. In fact, excellent precision in
duplicate samples can influence a decision about how to
treat data for a chemical that has sporadic blank con-
tamination or variable spiked sample or CRM recoveries
because it can indicate that the results are reproducible.
On the other hand, consistently poor precision for dust
wipe samples, for example, has informed our decision to
rely more heavily on measured air concentrations as an
indicator of home exposure [30]. Table 8 outlines our
approach for analyzing duplicate data.
Publication: how do we tell others about our data?
While it is imperative that a researcher has a thorough un-
derstanding of the quality of her own data, it is equally im-
portant that she clearly communicate the results of the
QA/QC review. When we considered the articles included
in our recent review of epidemiologic studies of environ-
mental chemicals and breast cancer [11], we identified
gaps in reporting and/or interpretation of QA/QC data,
an issue also noted by LaKind et al. [12]. To encourage
more regular and consistent reporting of QA/QC results,
in supplementary material we provide examples of the
Table 7 Blank correction
Approach (see Additional file 4 for example of this approach with real
data):
1. Which blanks to use?
□ If detects are spread across all types of blanks (e.g., field, solvent
method, matrix), we use all blanks for blank correction. Otherwise we
use field blanks. We try to keep our blank correction approach
consistent with our MRL approach.
2. Which chemicals get corrected?
□ If > 5 blanks:
○ For each chemical, we use a one-sided one sample sign test
(special case of binomial test with p = 0.5) to determine whether
the median of blanks is statistically significantly different from zero.
True and estimated detects are treated as positive values and non-
detects as negative values.
▪ We blank-correct chemicals with a sign test p-value < 0.05.
▪ However, if the number of blanks is relatively small (10 or
fewer) we consider blank correction even when the sign test does
not produce a significant result. The sign test does not take into
account the magnitude of the levels detected in the blanks nor
does it distinguish different types of blanks (i.e., field and lab).
• For example, if we have 3 field blanks and 4 lab blanks, and
we see consistent levels detected across all field blanks and all but
one lab blank, we would consider blank correcting even though
the sign test would produce p > 0.05.
□ If≤ 5 blanks (i.e., for a small dataset):
○ With five or fewer blanks, the sign test will never be significant.
In this case, we blank-correct chemicals with 100% detects in
blanks.
3. Blank correction:
□ Calculate the median value of the blanks, with non-detects set to ½
lab’s reporting limit and using all values (i.e., estimated and true
detects).
○ It is useful to pause here and assess the value being used for
blank correction. Is it based on an estimated value below the MRL?
What will be the percent change in the median, comparing the
original to the blank-corrected data?
□ Subtract median blank value from all sample results.
□ Subtract median blank value from the MRL (determined as in Table 6).
Reporting:
□ We are explicit about whatever procedure we use to decide
whether or not to perform blank correction (sign test or other) and
about the statistic (e.g., median, mean) and amount used for
correction.
□ Any presentation of measurements (e.g., summary statistics) should
use blank-corrected values because they may be compared with mea-
surements in other studies.
□ For statistical analyses such as regression and correlation performed
within the dataset, non-blank-corrected data can be used.
Table 8 Duplicates
Approach (see Additional file 4 for example of this approach with real
data):
1. Compute precision.
□ Compute & summarize average relative percent difference (RPD) for
duplicate pairs or, if ≥3 side-by-side samples, compute relative stand-
ard deviation (RSD):
○ If sample results have been normalized (e.g., mass converted to
concentration), compute precision with normalized values.
○ Compute only for pairs where both samples are detects.
○ Also consider precision restricted to pairs where both samples
are flagged as “true detects” above the MRL.
2. Visualize duplicate pairs.
□ This is a good point to pause and check your data and to note/
investigate anything that looks unusual (e.g., huge difference in
results for two members of a duplicate pair, how tight are detect/
non-detect pairs). See Additional file 4: Figure S10A-D for an example.
3. Average duplicates, with non-detects set to lab’s reporting limit.
□ Calculate average volume and concentration for each pair. Note,
can skip this step if only have mass data, or if results were reported
by lab as concentrations, rather than as masses that were then
normalized to concentrations.
□ Back calculate new average mass using average volume and
average concentration. Or, simply average the duplicate
measurements if only have mass data, or if results were reported by
lab as concentrations, rather than as masses that were then
normalized to concentrations.
□ Compare new average measurement to MRL to determine data
qualifier flag.
□ Combine duplicate averages back with rest of data.
Reporting:
□ In publications, we note the range of average RPDs across all
chemicals in our QA/QC discussion. We consider average RPD < 30%
to be “good” precision.
□ If a chemical has sporadic blank contamination or variable spike
recoveries, excellent precision can increase our confidence in the field
sample results.
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tables and plots (Additional file 2: Tables S3, S4, and Fig-
ure S1) we have used to communicate QA/QC findings in
our publications. Consistently publishing QA/QC findings
allows readers to think for themselves about the quality of
the data and can inform risk of bias assessments in a sys-
tematic review. QA/QC data also provides a basis for de-
termining whether further analyses of the published data
(e.g., comparisons to or pooling with other datasets) are
appropriate.
Conclusion
Several real examples from our data demonstrate that
close examination of lab and field quality control data is
worth the effort. By providing a detailed example of how
we have processed and drawn conclusions about our
own environmental exposure data (Additional file 4), we
aim to make our guidelines explicit and straight forward
so that others may adopt and build on them.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12940-019-0537-8.
Additional file 1: Table S1. Summary of our application of the
Navigation Guide Criteria for Low Risk of Bias Assessment for the
question: "Were exposure assessment methods robust?".
Additional file 2: Section I: Example lab correspondence. Section II:
Table S2. Summary statistics table shell. Table S3. Quality assurance and
quality control (QA/QC) summary table shell. Table S4. Findings and
actions from review of quality assurance and quality control (QA/QC)
data table shell. Section III: Figure S1. Distribution of surrogate recoveries
by study visit.
Additional file 3: Example of report formatting request to send to the
lab.
Additional file 4: Example QA/QC report.
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